Literature DB >> 8781698

Relations between various DNA-parameters and degree of malignancy in endometrial carcinoma.

G Naumann1, U Köhler, H Nenning, C Emmert, G Taubert, K Bilek.   

Abstract

120 imprint-cytology specimens obtained from standardized areas of 20 endometrial carcinomas were investigated by use of a computed-controlled image analysis system to determine special quantitative DNA-parameters. The stem line ploidy, the 2c deviation index (2cDI), the DNA-associated graduation of malignancy (DNA-MG) as well as the 5c exceeding rate (5cER) were calculated for each preparation. 85% of the imprint-cytology preparations had diploid stem lines, and aneuploidy was found in 15%. There were statistically significant correlations between the DNA-MG, the 5cER and the stem line ploidy as well as between the DNA-MG and the 5cER. The sensitivity of the 5cER was 76.6% in our study and so we cannot regard this parameter as prouding accurate information about tumor malignancy in endometrial carcinoma. Special DNA-parameters defined mathematically should be utilized for objective grading of tumor malignancy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781698     DOI: 10.1007/s004040050111

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  8 in total

1.  Algorithm for DNA-cytophotometric diagnosis and grading of malignancy.

Authors:  A Böcking; W Auffermann
Journal:  Anal Quant Cytol Histol       Date:  1986-12       Impact factor: 0.302

2.  [Variability of quantitative DNA parameters in endometrial carcinoma].

Authors:  U Köhler; G Naumann; A Nenning; G Taubert; K Bilek
Journal:  Zentralbl Gynakol       Date:  1994

3.  DNA ploidy in endometrial carcinoma: major objective prognostic factor.

Authors:  L C Britton; T O Wilson; T A Gaffey; S S Cha; H S Wieand; K C Podratz
Journal:  Mayo Clin Proc       Date:  1990-05       Impact factor: 7.616

4.  The relation between the results of cytophotometric examination of endometrial carcinoma and clinical course of these disease.

Authors:  U Köhler; G Taubert; K Bilek; A Nenning
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

5.  Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients.

Authors:  K C Podratz; T O Wilson; T A Gaffey; S S Cha; J A Katzmann
Journal:  Am J Obstet Gynecol       Date:  1993-04       Impact factor: 8.661

6.  Evaluation of DNA ploidy in endometrial cancer.

Authors:  M Ikeda; Y Watanabe; T Nanjoh; K Noda
Journal:  Gynecol Oncol       Date:  1993-07       Impact factor: 5.482

7.  Algorithm for a DNA-cytophotometric diagnosis and grading of malignancy.

Authors:  A Böcking; C P Adler; H H Common; M Hilgarth; B Granzen; W Auffermann
Journal:  Anal Quant Cytol       Date:  1984-03

8.  Effect of deoxyribonucleic acid ploidy status on survival of patients with carcinoma of the endometrium.

Authors:  C H Dyas; T K Simmons; C N Ellis; J M Austin; E E Partridge; L C Kilgore; C Reading; K Nelson; W S Blakemore
Journal:  Surg Gynecol Obstet       Date:  1992-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.